Abstract
Objective
To systematically review the literature assessing the role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in the differentiation of soft tissue sarcomas from benign lesions.
Materials and methods
A comprehensive literature search was performed with the following keywords: multiparametric magnetic resonance imaging, DCE-MR perfusion, soft tissue, sarcoma, and neoplasm. Original studies evaluating the role of DCE-MRI for differentiating benign soft-tissue lesions from soft-tissue sarcomas were included.
Results
Eighteen studies with a total of 965 imaging examinations were identified. Ten of twelve studies evaluating qualitative parameters reported improvement in discriminative power. One of the evaluated qualitative parameters was time-intensity curves (TIC), and malignant curves (TIC III, IV) were found in 74% of sarcomas versus 26.5% benign lesions. Six of seven studies that used the semiquantitative approach found it relatively beneficial. Four studies assessed quantitative parameters including Ktrans (contrast transit from the vascular compartment to the interstitial compartment), Kep (contrast return to the vascular compartment), and Ve (the volume fraction of the extracellular extravascular space) in addition to other parameters. All found Ktrans, and 3 studies found Kep to be significantly different between sarcomas and benign lesions. The values for Ve were variable. Additionally, eight studies assessed diffusion-weighted imaging (DWI), and 6 of them found it useful.
Conclusion
Of different DCE-MRI approaches, qualitative parameters showed the best evidence in increasing the diagnostic performance of MRI. Semiquantitative and quantitative approaches seemed to improve the discriminative power of MRI, but which parameters and to what extent is still unclear and needs further investigation.
Similar content being viewed by others
References
Garner HW, Kransdorf MJ. Musculoskeletal sarcoma: update on imaging of the post-treatment patient. Can Assoc Radiol J. 2016;67(1):12–20.
Lee JH, Yoon YC, Seo SW, Choi Y-L, Kim HS. Soft tissue sarcoma: DWI and DCE-MRI parameters correlate with Ki-67 labeling index. Eur Radiol. 2020;30(2):914–24.
Erlemann R, Reiser MF, Peters PE, Vasallo P, Nommensen B, Kusnierz-Glaz CR, et al. Musculoskeletal neoplasms: static and dynamic Gd-DTPA-enhanced MR imaging. Radiology. 1989;171(3):767–73.
Erlemann R, Sciuk J, Wuisman P, Bene D, Edel G, Ritter J, et al. Dynamic MR tomography in diagnosis of inflammatory and tumorous space-occupying growths of the musculoskeletal system. Rofo. 1992;156(4):353–9.
Vallières M, Serban M, Benzyane I, Ahmed Z, Xing S, El Naqa I, et al. Investigating the role of functional imaging in the management of soft-tissue sarcomas of the extremities. Phys Imaging Radiat Oncol. 2018;6:53–60.
Rosenkrantz AB, Sabach A, Babb JS, Matza BW, Taneja SS, Deng F-M. Prostate cancer: comparison of dynamic contrast-enhanced MRI techniques for localization of peripheral zone tumor. Am J Roentgenol. 2013;201(3):W471–W8.
Fusco R, Sansone M, Filice S, Carone G, Amato DM, Sansone C, et al. Pattern recognition approaches for breast cancer DCE-MRI classification: a systematic review. J Med Biol Eng. 2016;36(4):449–59.
Tabriz HM, Obohat M, Vahedifard F, Eftekharjavadi A. Survey of mast cell density in transitional cell carcinoma. Iran J Pathol. 2021;16(2):119.
Tuncbilek N, Karakas HM, Okten OO. Dynamic contrast enhanced MRI in the differential diagnosis of soft tissue tumors. Eur J Radiol. 2005;53(3):500–5.
Fayad LM, Mugera C, Soldatos T, Flammang A, Del Grande F. Technical innovation in dynamic contrast-enhanced magnetic resonance imaging of musculoskeletal tumors: an MR angiographic sequence using a sparse k-space sampling strategy. Skelet Radiol. 2013;42(7):993–1000.
Ziayee F, Ullrich T, Blondin D, Irmer H, Arsov C, Antoch G, et al. Impact of qualitative, semi-quantitative, and quantitative analyses of dynamic contrast-enhanced magnet resonance imaging on prostate cancer detection. PLoS One. 2021;16(4):e0249532.
Leplat C, Hossu G, Chen B, De Verbizier J, Beaumont M, Blum A, et al. Contrast-Enhanced 3-T Perfusion MRI with quantitative analysis for the characterization of musculoskeletal tumors: is it worth the trouble? Am J Roentgenol. 2018;211(5):1092–8.
Gimber LH, Chadaz TS, Flake W, Taljanovic MS. Advanced MR imaging of musculoskeletal tumors: an overview. Semin Roentgenol. 2019;54(2):149–61.
Sujlana P, Skrok J, Fayad LM. Review of dynamic contrast-enhanced MRI: technical aspects and applications in the musculoskeletal system. J Magn Reson Imaging. 2018;47(4):875–90.
Del Grande F, Subhawong T, Weber K, Aro M, Mugera C, Fayad LM. Detection of soft-tissue sarcoma recurrence: added value of functional MR imaging techniques at 3.0 T. Radiology. 2014;271(2):499–511.
Van Rijswijk CS, Geirnaerdt MJ, Hogendoorn PC, Taminiau AH, van Coevorden F, Zwinderman AH, et al. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy. Radiology. 2004;233(2):493–502.
Vilanova JC, Baleato-Gonzalez S, Romero MJ, Carrascoso-Arranz J, Luna A. Assessment of musculoskeletal malignancies with functional MR imaging. Magn Reson Imaging Clin N Am. 2016;24(1):239–59.
Malek M, Gity M, Alidoosti A, Oghabian Z, Rahimifar P, Seyed Ebrahimi SM, et al. A machine learning approach for distinguishing uterine sarcoma from leiomyomas based on perfusion weighted MRI parameters. Eur J Radiol. 2019;110:203–11.
Van der Woude HJ, Verstraete KL, Hogendoorn PC, Taminiau AH, Hermans J, Bloem JL. Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization? Radiology. 1998;208(3):821–8.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–e34.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36.
Goto A, Takeuchi S, Sugimura K, Maruo T. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer. 2002;12(4):354–61.
Tacikowska M. Dynamic magnetic resonance imaging in soft tissue tumors - assessment of the diagnostic value of tumor enhancement rate indices. Med Sci Monit. 2002;8(4):MT53–MT7.
Barile A, Regis G, Masi R, Maggiori M, Gallo A, Faletti C, et al. Musculoskeletal tumours: preliminary experience with perfusion MRI. Radiol Med. 2007;112(4):550–61.
Demehri S, Belzberg A, Blakeley J, Fayad LM. Conventional and functional MR imaging of peripheral nerve sheath tumors: initial experience. AJNR Am J Neuroradiol. 2014;35(8):1615–20.
Yildirim A, Dogan S, Okur A, Imamoglu H, Karabiyik O, Ozturk M. The role of dynamic contrast enhanced magnetic resonance imaging in differentiation of soft tissue masses. Eur J Gen Med. 2016;13(1):37–44.
Del Grande F, Ahlawat S, Subhangwong T, Fayad LM. Characterization of indeterminate soft tissue masses referred for biopsy: what is the added value of contrast imaging at 3.0 tesla? J Magn Reson Imaging. 2017;45(2):390–400.
Rio G, Lima M, Gil R, Horta M, Cunha TM. T2 hyperintense myometrial tumors: can MRI features differentiate leiomyomas from leiomyosarcomas? Abdom Radiol (NY). 2019;44(10):3388–97.
Dodin G, Salleron J, Jendoubi S, Abou Arab W, Sirveaux F, Blum A, et al. Added-value of advanced magnetic resonance imaging to conventional morphologic analysis for the differentiation between benign and malignant non-fatty soft-tissue tumors. Eur Radiol. 2020;
Lee SK, Jee WH, Jung CK, Chung YG. Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and malignant soft tissue tumors. Br J Radiol. 2020;93(1115):20191035.
Zhang Y, Yue B, Zhao X, Chen H, Sun L, Zhang X, et al. Benign or malignant characterization of soft-tissue tumors by using semiquantitative and quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging. Can Assoc Radiol J. 2020;71(1):92–9.
Zheng T, Du J, Yang L, Dong Y, Wang Z, Liu D, Wu S, Shi Q, Wang X, Liu L. Evaluation of risk classifications for gastrointestinal stromal tumor using multi-parameter magnetic resonance analysis. Abdom Radiol (NY). 2021;46:1506–18.
Shannon BA, Ahlawat S, Morris CD, Levin AS, Fayad LM. Do contrast-enhanced and advanced MRI sequences improve diagnostic accuracy for indeterminate lipomatous tumors? Radiol Med. 2021:1–10.
Yu Q, Zhu Y, Huang R, Li Y, Song L, Zhang X, et al. Diagnosis and differential diagnosis of dermatofibrosarcoma protuberans: utility of high-resolution dynamic contrast-enhanced (DCE) MRI. Skin Res Technol. 2022;28(5):651–63.
Mahmood N, Al Rashid A, Ladumor S, Mohamed M, Kambal A, Saloum N, et al. The role of multiparametric MRI in differentiating uterine leiomyosarcoma from benign degenerative leiomyoma and leiomyoma variants: a retrospective analysis. Clin Radiol. 2023;78(1):47–54.
Balçik Ç, Hüseyin AK, İncesu L. Evaluating of parotid gland tumours according to diffusion weighted MRI. Eur J Gen Med. 2014;11(2):77–84.
Coudert H, Mirafzal S, Dissard A, Boyer L, Montoriol P-F. Multiparametric magnetic resonance imaging of parotid tumors: a systematic review. Diagn Interv Imaging. 2021;102(3):121–30.
Noebauer-Huhmann I-M, Amann G, Krssak M, Panotopoulos J, Szomolanyi P, Weber M, et al. Use of diagnostic dynamic contrast-enhanced (DCE)-MRI for targeting of soft tissue tumour biopsies at 3T: preliminary results. Eur Radiol. 2015;25:2041–8.
Zhang N, Zhang L, Qiu B, Meng L, Wang X, Hou BL. Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas. J Magn Reson Imaging. 2012;36(2):355–63.
Dijkhoff RA, Beets-Tan RG, Lambregts DM, Beets GL, Maas M. Value of DCE-MRI for staging and response evaluation in rectal cancer: a systematic review. Eur J Radiol. 2017;95:155–68.
Roberts C, Issa B, Stone A, Jackson A, Waterton JC, Parker GJ. Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies. J Magn Reson Imaging. 2006;23(4):554–63.
El Khouli RH, Macura KJ, Kamel IR, Jacobs MA, Bluemke DA. 3-T dynamic contrast-enhanced MRI of the breast: pharmacokinetic parameters versus conventional kinetic curve analysis. Am J Roentgenol. 2011;197(6):1498–505.
Funding
Majid Chalian, M.D. received the RSNA R&E Scholar grant and Boeing Technology Development grant
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shomal Zadeh, F., Pooyan, A., Alipour, E. et al. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in differentiation of soft tissue sarcoma from benign lesions: a systematic review of literature. Skeletal Radiol 53, 1343–1357 (2024). https://doi.org/10.1007/s00256-024-04598-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-024-04598-3